Category: us corporate news

us corporate news

SailPoint Reports 28% ARR Growth to $1.125 Billion in Fiscal Year 2026, Driven by Strong SaaS Performance

Minichart

March 18, 2026

SailPoint, Inc. Fiscal 2026 Full Year and Q4 Financial Resul...

Continue Reading 0

us corporate news

Tecnoglass Declares $0.15 Quarterly Dividend for Q1 2026, Payable April 30

Minichart

March 18, 2026

Tecnoglass Announces First Quarter 2026 Dividend Tecno...

Continue Reading 0

us corporate news

EDAP TMS S.A. Leads Global Growth in Robotic HIFU for Prostate Cancer with Strong Clinical Evidence and Reimbursement 910111213141516

Minichart

March 18, 2026

EDAP TMS S.A. Presents at Oppenheimer 36th Annual Healthcare...

Continue Reading 0

us corporate news

Spire Global Reports Strong Q4 and Full Year 2025 Results with Improved Financials and Satellite Launches

Minichart

March 18, 2026

Spire Global, Inc. Reports Q4 and Full Year 2025 Results: Ke...

Continue Reading 0

us corporate news

Jabil Reports Strong Q2 2026 Results, Raises Full-Year Outlook and Delivers Robust Core EPS and Revenue Growth

Minichart

March 18, 2026

Jabil Inc. Q2 2026 Financial Results: Detailed Report for In...

Continue Reading 0

us corporate news

McCormick & Company 8-K Filing March 12, 2026: Common Stock Details, NYSE Listings, and Company Information

Minichart

March 18, 2026

McCormick & Co Inc. 8-K Filing: Detailed Investor Report ...

Continue Reading 0

us corporate news

Ovid Therapeutics Expands OV329 Epilepsy Program, Launches Phase 1 OV4071 Trial, and Reports Strong 2025 Financial Results

Minichart

March 18, 2026

Ovid Therapeutics Announces Major Pipeline and Financial Mil...

Continue Reading 0

us corporate news

Incannex Highlights $75 Million Cash, No Debt, and Advances IHL-42X and PSX-001 Clinical Programs

Minichart

March 18, 2026

Incannex Healthcare Highlights Strong Financial Position and...

Continue Reading 0

us corporate news

1606 Corp. Engages Moody Capital Solutions as Exclusive Placement Agent to Support Texas Data Center and AI Infrastructure Acquisition 1

Minichart

March 18, 2026

1606 Corp. Engages Moody Capital Solutions as Exclusive Plac...

Continue Reading 0

us corporate news

MetaVia Advances DA-1726 GLP-1/Glucagon Dual Agonist for Obesity With IRB Approval for Higher-Dose Phase 1 Trial

Minichart

March 18, 2026

MetaVia Inc. Secures IRB Approval for Higher-Dose Phase 1 St...

Continue Reading 0